CB Insights mapped the 50 winners across eight core functional categories, reflecting an industry sharply bifurcated between expanding direct clinical capacity and dismantling operational overhead:
Notably, 26 of the 50 winners focus on eliminating administrative work—from insurance approvals to patient coordination—that diverts clinician time away from direct care.
Rather than restricting artificial intelligence to ambient note-taking and back-office paperwork, leading startups are deploying clinician-supervised AI agents to execute front-line clinical tasks—assessing symptoms, monitoring chronic disease vitals, and recommending prescription renewals. Doctronic pairs AI symptom assessments with virtual physician care; despite regulatory scrutiny over its Utah prescription-renewal pilot, company-reported data indicates physicians agreed with 91 percent of AI-recommended renewals. Cadence deploys clinician-supervised AI agents to monitor patients and manage medications, expanding its senior-care footprint through an April 2026 partnership with Memorial Hermann. Meanwhile, Tucuvi’s voice AI agent, LOLA—the first voice AI in Europe to secure Class IIb medical device certification—conducts automated clinical follow-up calls and escalates acute concerns across more than 10 percent of Spain’s public hospitals.
As specialty and novel therapies grow more complex and expensive, an average of 65 percent of first-year prescriptions across 99 medicines launched between 2020 and 2024 went unfilled due to payer rejections and patient abandonment. Startups are deploying autonomous agents to bridge fragmented workflows across prior authorization, financial assistance, and pharmacy fulfillment. Forus—which raised a $150 million Series C at a $3 billion valuation—coordinates insurance approvals and pharmacy fulfillment free to patients and providers via biopharma sponsorships. Latent automates medication authorizations and appeals, onboarding Cleveland Clinic and AdventHealth in September 2026, while Courier Health links biopharma, pharmacy, and provider support workflows, and TJM Labs scales pharmacy voice and intake automation following its July 2026 acquisitions of Pharmesol and Encore Rx Automation.
Source link







